Cochrane Abstracts
Losigamone add‐on therapy for focal epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Losigamone Add‐on Therapy for Focal Epilepsy." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435542/all/Losigamone_add‐on_therapy_for_focal_epilepsy.
Losigamone add‐on therapy for focal epilepsy. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435542/all/Losigamone_add‐on_therapy_for_focal_epilepsy. Accessed May 6, 2025.
Losigamone add‐on therapy for focal epilepsy. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435542/all/Losigamone_add‐on_therapy_for_focal_epilepsy
Losigamone Add‐on Therapy for Focal Epilepsy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 May 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435542/all/Losigamone_add‐on_therapy_for_focal_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Losigamone add‐on therapy for focal epilepsy
ID - 435542
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435542/all/Losigamone_add‐on_therapy_for_focal_epilepsy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
